Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 2
1999 1
2000 1
2002 1
2005 3
2006 2
2007 2
2008 3
2009 2
2010 2
2011 1
2012 7
2013 10
2014 13
2015 8
2016 5
2017 15
2018 8
2019 10
2020 9
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

99 results
Results by year
Filters applied: . Clear all
Page 1
GAPDH Expression Predicts the Response to R-CHOP, the Tumor Metabolic Status, and the Response of DLBCL Patients to Metabolic Inhibitors.
Chiche J, Reverso-Meinietti J, Mouchotte A, Rubio-PatiƱo C, Mhaidly R, Villa E, Bossowski JP, Proics E, Grima-Reyes M, Paquet A, Fragaki K, Marchetti S, Briere J, Ambrosetti D, Michiels JF, Molina TJ, Copie-Bergman C, Lehmann-Che J, Peyrottes I, Peyrade F, de Kerviler E, Taillan B, Garnier G, Verhoeyen E, Paquis-Flucklinger V, Shintu L, Delwail V, Delpech-Debiais C, Delarue R, Bosly A, Petrella T, Brisou G, Nadel B, Barbry P, Mounier N, Thieblemont C, Ricci JE. Chiche J, et al. Cell Metab. 2019 Jun 4;29(6):1243-1257.e10. doi: 10.1016/j.cmet.2019.02.002. Epub 2019 Feb 28. Cell Metab. 2019. PMID: 30827861 Free article.
New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments.
Dufies M, Grytsai O, Ronco C, Camara O, Ambrosetti D, Hagege A, Parola J, Mateo L, Ayrault M, Giuliano S, GrĆ©pin R, Lagarde N, Montes M, Auberger P, Demange L, Benhida R, PagĆØs G. Dufies M, et al. Theranostics. 2019 Jul 9;9(18):5332-5346. doi: 10.7150/thno.34681. eCollection 2019. Theranostics. 2019. PMID: 31410218 Free PMC article.
Ɖvaluation du profil plasmatique des microARNs, comme marqueur diagnostic du cancer localisĆ© de la prostate avec confirmation des analyses par prĆ©lĆØvement tissulaire sur spĆ©cimens aprĆØs prostatectomie radicale Ć©largie.
Tibi B, Durand M, Rouscoff Y, Lee J, Mauduit C, Ambrosetti D, Mahate Z, Wijeratne V, Severac F, Carpentier X, Marsaud A, Mentine N, Quintens H, Amiel J, Chevallier D, Benahmed M. Tibi B, et al. Prog Urol. 2014 Nov;24(13):787-8. doi: 10.1016/j.purol.2014.08.014. Epub 2014 Oct 30. Prog Urol. 2014. PMID: 26461539 French. No abstract available.
Identification of a new aggressive axis driven by ciliogenesis and absence of VDAC1-Ī”C in clear cell Renal Cell Carcinoma patients.
Fabbri L, Dufies M, Lacas-Gervais S, Gardie B, Gad-Lapiteau S, Parola J, Nottet N, Meyenberg Cunha de Padua M, Contenti J, Borchiellini D, Ferrero JM, Leclercq NR, Ambrosetti D, Mograbi B, Richard S, Viotti J, Chamorey E, Sadaghianloo N, Rouleau M, Craigen WJ, Mari B, Clavel S, PagĆØs G, PouyssĆ©gur J, Bost F, Mazure NM. Fabbri L, et al. Theranostics. 2020 Feb 3;10(6):2696-2713. doi: 10.7150/thno.41001. eCollection 2020. Theranostics. 2020. PMID: 32194829 Free PMC article.
UBTD1 is a mechano-regulator controlling cancer aggressiveness.
Torrino S, Roustan FR, Kaminski L, Bertero T, Pisano S, Ambrosetti D, Dufies M, Uhler JP, Lemichez E, Mettouchi A, Gesson M, Laurent K, Gaggioli C, Michiels JF, Lamaze C, Bost F, Clavel S. Torrino S, et al. EMBO Rep. 2019 Apr;20(4):e46570. doi: 10.15252/embr.201846570. Epub 2019 Feb 25. EMBO Rep. 2019. PMID: 30804013 Free PMC article.
Oxytocin Controls Chondrogenesis and Correlates with Osteoarthritis.
Roux CH, Pisani DF, Gillet P, Fontas E, Yahia HB, Djedaini M, Ambrosetti D, Michiels JF, Panaia-Ferrari P, Breuil V, Pinzano A, Amri EZ. Roux CH, et al. Int J Mol Sci. 2020 May 31;21(11):3966. doi: 10.3390/ijms21113966. Int J Mol Sci. 2020. PMID: 32486506 Free PMC article.
99 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page